Nachrichten

Self-reactive T cells driving chronic autoimmune disease identified

In autoimmune diseases autoantigen-specific T cells orchestrate the pathogenic immune reaction against self. Saggau & Bacher et al. show that these cells acquire an unexpected Foxp3+ “exhausted” T helper (ThEx) cell phenotype and shut down their activation program. Importantly this allows ThEx cells to escape current therapies that target activated T cells. In  this way ThEx cells persist for many  years and can be reactivated, providing an explanation how ThEx cells drive disease chronicity and contribute to disease flares. Targeting of ThEx cells may enable long-lasting and durable therapies of autoimmune diseases. Read more.

Self-reactive T cells driving chronic autoimmune disease identified
03.09.2024
In autoimmune...
Immunogenic cell death in cancer- review from Dieter Adam and colleagues in Nature Reviews Cancer
12.03.2024
Most metastatic...
New cell therapy for type 1 Diabetes
20.02.2024
The groups...
Petra Bacher awarded the Georges Köhler Prize 2023
27.09.2023
The German...
Schleswig-Holstein funds four new professorships of excellence in inflammation research
19.09.2023
The state’s...
New DFG funded Transregio on regulatory T cells
01.01.2023
The TRR...
Neue T-Zelldiagnostik für akute Tuberkulose entwickelt
15.08.2022
Ein Forschungsteam...
Schutz vor Corona: Erfahrung ist beim Immunsystem nicht immer ein Vorteil
14.08.2022
Warum die...
ERC Starting Grant
10.01.2022
1.5 million...
Neuer Sonderforschungsbereich
01.01.2022
Drei Arbeitsgruppen...